Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flynn

Showing results (1171-1180 of 1,203) with videos related to

Pageof 121
Sort By:
The Journal of Clinical Investigation|July 18, 2017
Ibrutinib treatment improves T cell number and function in CLL patientsMeixiao Long, Kyle Beckwith, Priscilla Do, et al.
Environmental Toxicology and Chemistry|July 25, 2013
Cross-species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactoneCarlie A LaLone, Daniel L Villeneuve, Jenna E Cavallin, et al.
The Journal of Bone and Joint Surgery. American Volume|May 17, 2013
Evaluating the extent of clinical uncertainty among treatment options for patients with early-onset scoliosisJacqueline Corona, Daniel J Miller, Jenny Downs, et al.
JAMA Oncology|July 17, 2015
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic LeukemiaKami J Maddocks, Amy S Ruppert, Gerard Lozanski, et al.
Drug and Alcohol Dependence|November 10, 2018
Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populationsAndrea M Hussong, Nisha C Gottfredson, Dan J Bauer, et al.
Plos One|April 24, 2018
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trialAnna Turkova, Cecilia L Moore, Karina Butler, et al.
AIDS (London, England)|March 1, 2024
Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trialSufia Dadabhai, Victoria B Chou, Mauricio Pinilla, et al.
Ebiomedicine|May 22, 2022
Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug developmentAditya H Gaur, John C Panetta, Amber M Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk diseaseThomas S Lin, Amy S Ruppert, Amy J Johnson, et al.
Blood|June 28, 2015
Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 studySamantha M Jaglowski, Jeffrey A Jones, Veena Nagar, et al.
Pageof 121

Showing results (1171-1180 of 1,203) with videos related to

Sort By:
Pageof 121
The Journal of Clinical Investigation|July 18, 2017
Ibrutinib treatment improves T cell number and function in CLL patientsMeixiao Long, Kyle Beckwith, Priscilla Do, et al.
Environmental Toxicology and Chemistry|July 25, 2013
Cross-species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactoneCarlie A LaLone, Daniel L Villeneuve, Jenna E Cavallin, et al.
The Journal of Bone and Joint Surgery. American Volume|May 17, 2013
Evaluating the extent of clinical uncertainty among treatment options for patients with early-onset scoliosisJacqueline Corona, Daniel J Miller, Jenny Downs, et al.
JAMA Oncology|July 17, 2015
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic LeukemiaKami J Maddocks, Amy S Ruppert, Gerard Lozanski, et al.
Drug and Alcohol Dependence|November 10, 2018
Approaches for creating comparable measures of alcohol use symptoms: Harmonization with eight studies of criminal justice populationsAndrea M Hussong, Nisha C Gottfredson, Dan J Bauer, et al.
Plos One|April 24, 2018
Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trialAnna Turkova, Cecilia L Moore, Karina Butler, et al.
AIDS (London, England)|March 1, 2024
Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trialSufia Dadabhai, Victoria B Chou, Mauricio Pinilla, et al.
Ebiomedicine|May 22, 2022
Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug developmentAditya H Gaur, John C Panetta, Amber M Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk diseaseThomas S Lin, Amy S Ruppert, Amy J Johnson, et al.
Blood|June 28, 2015
Safety and activity of BTK inhibitor ibrutinib combined with ofatumumab in chronic lymphocytic leukemia: a phase 1b/2 studySamantha M Jaglowski, Jeffrey A Jones, Veena Nagar, et al.
Pageof 121